半乳甘露聚糖曲霉抗原在急性侵袭性真菌性鼻窦炎诊断中的作用
本研究回顾性分析2006至2017年78例接受病理评估的侵袭性真菌性鼻窦炎高危患者,其中38例同时有病理和半乳甘露聚糖检测。结果显示半乳甘露聚糖敏感度44.8%、特异度100%、阳性预测值100%、阴性预测值36%,阳性结果与病理诊断一致,但敏感度低,不宜单独作为筛查工具。
要点
- 血清半乳甘露聚糖阳性可提示高危患者存在急性侵袭性真菌性鼻窦炎。
- 半乳甘露聚糖特异度和阳性预测值均为100%,但敏感度仅44.8%。
- 半乳甘露聚糖阴性不能排除急性侵袭性真菌性鼻窦炎,需结合病理。
核心结论
- 血清半乳甘露聚糖阳性可提示高危患者存在急性侵袭性真菌性鼻窦炎,但因其敏感度低,不宜单独作为筛查工具。
研究设计与样本
- 回顾性研究,利用Co-Path病理记录检索2006至2017年接受侵袭性真菌性鼻窦炎病理评估的患者,最终纳入78例,其中38例同时有病理和半乳甘露聚糖检测。
主要发现
- 半乳甘露聚糖敏感度44.8%(95%CI 26.5%至64.3%),特异度100%(95%CI 66.4%至100%)。
- 阳性预测值100%(95%CI 74.3%至100%),阴性预测值36%(95%CI 18.0%至57.5%)。
- 半乳甘露聚糖状态与全因死亡率无显著关联。
临床怎么用
- 对临床高度怀疑急性侵袭性真菌性鼻窦炎的高危患者,半乳甘露聚糖阳性可支持诊断。
- 不应依赖半乳甘露聚糖阴性排除急性侵袭性真菌性鼻窦炎,病理诊断仍为金标准。
局限性
- 回顾性研究,样本量有限,仅38例同时有病理和半乳甘露聚糖检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pathologic diagnosis remains the gold standard for final diagnosis of acute invasive fungal sinusitis (AIFS); however, other less invasive tests could suggest the presence of AIFS in at-risk populations where early diagnosis is crucial. Serum galactomannan Aspergillus antigen has been shown to correlate with a diagnosis of invasive pulmonary aspergillosis; however, it has not adequately been evaluated in regard to AIFS. The objective of this study is to evaluate the statistical relevance of galactomannan in predicting diagnosis of AIFS. METHODS: This study was a retrospective review of pathologic records using Co-Path from 2006 to 2017, incorporating 2 separate searches with designated criteria identifying patients who received pathologic evaluation for invasive fungal sinusitis. Electronic medical records were subsequently reviewed. After exclusions isolating at-risk populations and removing duplications, 78 cases were reviewed using the indicated search criteria. Of these, 38 met further criteria of having had both pathologic evaluation and galactomannan analysis. Statistical variables were assessed, as well as all-cause mortality. Peak and closest galactomannan levels were evaluated. RESULTS: Overall, galactomannan had a sensitivity of 44.8% (95% confidence interval [CI], 26.5% to 64.3%), specificity of 100% (95% CI, 66.4% to 100%), positive predictive value of 100% (95% CI, 74.3% to 100%), and negative predictive value of 36% (95% CI, 18.0% to 57.5%). No significant association was observed in galactomannan status and mortality in this patient population. CONCLUSION: Positive serum galactomannan can be an indication of AIFS in patients with a high clinical suspicion. In our study, a positive galactomannan always correlated with a positive pathologic diagnosis. However, given its low sensitivity, one must use caution in relying on galactomannan as a screening tool in diagnosis of AIFS.
引用
- Melancon CC, Lindsey J, Russell GB, et al. The role of galactomannan Aspergillus antigen in diagnosing acute invasive fungal sinusitis. Int Forum Allergy Rhinol. 2018. PMID: 30358938. doi:10.1002/alr.22225
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。